Share
Journal Information
Issue
Vol. 45. Issue S3.XIV Eurasian Hematology Oncology Congress
Pages S1-S48 (October 2023)
Adult speaker presentations
Induction therapy choices and responses in a third world country: A single center study from Pakistan
Amjad Zafar, Parnia Ansari, Rishma Nadeem, Iqra Majeed, Mobeen Ud din, Fareeha Sheikh, Kausar Bano
Hematol Transfus Cell Ther. 2023;45 Supl 3:S1
Full text access
Bone marrow transplantation versus chimeric antigen receptor T cells (CAR-T) therapy for hematological malignancies
Arnon Nagler, on behalf of the Sheba Team
Hematol Transfus Cell Ther. 2023;45 Supl 3:S1-S2
Full text access
The revolution in frontline treatment of Multiple Myeloma
Claudio Cerchione
Hematol Transfus Cell Ther. 2023;45 Supl 3:S2
Full text access
CML 2023 - State Of The Art And Cutting Edge İssues
Pia Raanani
Hematol Transfus Cell Ther. 2023;45 Supl 3:S3
Full text access
Management Of Early Relapsed Follicular Lymphoma Debate Favoring Non-Transplant Options
Murat Özbalak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S3
Full text access
Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
Carmino Antonio de Souza, Guilherme Duffles
Hematol Transfus Cell Ther. 2023;45 Supl 3:S4
Full text access
MDS 2023: State of The Art
Moshe Mittelman
Hematol Transfus Cell Ther. 2023;45 Supl 3:S4-S5
Full text access
Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN
Hanan Hamed
Hematol Transfus Cell Ther. 2023;45 Supl 3:S5
Full text access
Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China
Lv Lulu
Hematol Transfus Cell Ther. 2023;45 Supl 3:S5-S6
Full text access
Personalized Dendritic Cell Vaccines
Anzhelika Alexandrovna Melnikova, Lyudmila Yurievna Grivtsova
Hematol Transfus Cell Ther. 2023;45 Supl 3:S6
Full text access
CPi -Clalit Proactive and Preventative Intervention
Doron Netzer
Hematol Transfus Cell Ther. 2023;45 Supl 3:S6-S7
Full text access
Pediatric presentations
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS
Nurşah Eker
Hematol Transfus Cell Ther. 2023;45 Supl 3:S8
Full text access
STEM CELL TRANSPLANTATION AS A TREATMENT OPTION FOR RELAPSED/REFRACTORY GERM CELL TUMORS
Başak Adaklı Aksoy
Hematol Transfus Cell Ther. 2023;45 Supl 3:S8-S9
Full text access
CURRENT THERAPIES PRIMARY LANGERHANS CELL HYSTIOCYTOSIS
Deniz Tuğcu
Hematol Transfus Cell Ther. 2023;45 Supl 3:S9-S10
Full text access
THROMBOSIS IN CHILDHOOD LEUKEMIA AND LYMPHOMA
Hasan Fatih Çakmaklı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S10
Full text access
CANCER TREATMENT-RELATED CARDIOTOXICITY: OPTIMIZING HEART HEALTH FROM DIAGNOSIS TO LONG-TERM FOLLOW-UP
Melissa M. Hudson
Hematol Transfus Cell Ther. 2023;45 Supl 3:S10-S11
Full text access
TRANSFUSION IN PEDIATRIC ONCOLOGY
Suheyla Ocak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S11
Full text access
APPROACH TO PAIN MANAGEMENT
Tuba Eren
Hematol Transfus Cell Ther. 2023;45 Supl 3:S11-S12
Full text access
Oral presentations
THE RELATIONSHIP BETWEEN POLICYTEMIA VERA AND METABOLIC SYNDROME: THE SINGLE CENTER EXPERIENCE
Cem Selim
Hematol Transfus Cell Ther. 2023;45 Supl 3:S13
Full text access
THE OUTCOME OF PERIPHERAL T-CELL LYMPHOMA PATIENTS FAILING FIRST-LINE THERAPY, FROM PROSPECTIVE COHORT OF T-CELL BRAZIL PROJECT
Carmino De Souza, Eliana Miranda, Jamila Tavares, Renata LR Baptista, Karin C Cecyn, Juliana Pereira, Marcelo Bellesso, Samuel S Medina, ... Carlos S Chiattone
Hematol Transfus Cell Ther. 2023;45 Supl 3:S13-S14
Full text access
IBRUTİNİB-OBİNUTUZUMAB COMBİNATİON THERAPY İN THE TREATMENT OF RELAPSED NODAL MARGİNAL ZONE LYMPHOMA: A CASE STUDY
Nuray Gül Açar, İbrahim Halil Açar, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S14
Full text access
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VERSUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA (IKEMA): FINAL OVERALL SURVIVAL ANALYSIS
Ecenur Guder Arslan, Kwee Yong, Thomas Martın, Meletios Dımopoulos, Joseph Mıkhael, Marcelo Capra, Thierry Facon, Roman Hájek, ... Philippe Moreau
Hematol Transfus Cell Ther. 2023;45 Supl 3:S14-S15
Full text access
REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY
Ozgur Pektas, Prakash Navaratnam, Tanvi Rajput, Howard S. Frıedman, Ece Demırkır, Christina Tekle, Peggy Lın
Hematol Transfus Cell Ther. 2023;45 Supl 3:S15
Full text access
URETERAL AMYLOİDOSİS: A CASE REPORT OF SUCCESSFUL MANAGEMENT WİTH SURGERY, RADİATİON, AND CHEMOTHERAPY
İbrahim Halil Açar, Nuray Gül Açar, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S15-S16
Full text access
THE ROLE OF ADAMTS13 ACTIVITY LEVELS ON DISEASE EXACERBATION OR RELAPSE IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA: POST HOC ANALYSIS OF THE PHASE 3 HERCULES AND POST-HERCULES STUDIES
Johanna KREMER HOVINGA, Javier DE LA RUBIA, Katerina PAVENSKI, Ara METJIAN, Paul KNÖBL, Flora PEYVANDI, Spero CATALAND, Paul COPPO, ... Marie SCULLY
Hematol Transfus Cell Ther. 2023;45 Supl 3:S16
Full text access
EVALUATION OF VITAMIN D STATUS IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA
Rafiye Ciftciler, Cevdet Yıldırımel, Ali Erdinç Çiftçiler, Esra Seçkin, Mehmet Dağlı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S17
Full text access
CHANGES IN MUCOSA-ASSOCIATED INVARIANT T CELLS (MAIT), ASSOCIATED CYTOKINES, AND MR-1+ CELL NUMBER AND PHENOTYPE IN THE PERIPHERAL BLOOD OF PEDIATRIC ITP PATIENTS WITH AND WITHOUT ELTROMBOPAG THERAPY
Ahmet Eken, Metin Çil, Zehra Busra Azizoglu, Ramazan Üzen, Nazly Najat ASAAD, Sahin CALIK, Koray DORTERLER, Enes Mehmet Turkoglu, ... Ekrem Ünal
Hematol Transfus Cell Ther. 2023;45 Supl 3:S17
Full text access
LONG-TERM OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY HODGKIN AND NON-HODGKIN LYMPHOMA: MULTI-CENTER EXPERINCE FROM TURKEY
Ayse Uysal, Nur Soyer, Hakan Ozdogu, Hakan Goker, Olgu Erkin Cınar, Burak Devecı, Asu Fergun Yılmaz, Isık Kaygusuz Atagunduz, ... Filiz Vural
Hematol Transfus Cell Ther. 2023;45 Supl 3:S18
Full text access
INCREASED CAROTID INTIMA MEDIA THICKNESS AS AN INDICATOR OF INCREASED CARDIOVASCULAR RISK IN PATIENTS WITH PRIMARY FAMILIAL ERYTHROCYTOSIS
Alpay Yesılaltay, Hasan Değirmenci
Hematol Transfus Cell Ther. 2023;45 Supl 3:S18-S19
Full text access
OUTCOME OF APLASTIC ANEMIA ACCORDING TO DISEASE SEVERITY
Alfadil Haroon, Syed Osman Ahmed Ahmed, Hazzaa Alzahrani, Riad El Fakih, Ali Alahmari, Alfadel Alshaibani, Naeem Chaudhri, Fahad Almohareb, ... Mahmoud Aljurf
Hematol Transfus Cell Ther. 2023;45 Supl 3:S19-S20
Full text access
GLOBAL RESEARCH PATTERNS ON BLOOD DONOR DEFERRAL: AN ANALYSIS OF THEMES, TRENDS, AND INFLUENCE
Birol Güvenç, İbrahim Halil Açar, Şule Menziletoğu Yıldız
Hematol Transfus Cell Ther. 2023;45 Supl 3:S20
Full text access
UNUSUAL PRESENTATİON OF RHABDOMYOSARCOMA WİTH BONE MARROW INVOLVEMENT AND CERVİCAL MASS: A 17-YEAR-OLD FEMALE CASE REPORT
Nuray Gül Açar, İbrahim Halil Açar, Berksoy Şahin, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S20-S21
Full text access
NEW MOLECULAR TARGETS IN CANCER CELL BIOENERGETIC PATHWAYS
Tyumin Ivan
Hematol Transfus Cell Ther. 2023;45 Supl 3:S21
Full text access
THE COEXİSTENCE OF NOVEL MUTATİONS OF FX, DİMETHYLGLYCİNE DEHYDROGENASE GENES WİTH FAMİLİAL EPİSODİC PAİN SYNDROME: A CASE REPORT
Hatice Mine Çakmak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S21-S22
Full text access
ASSESSMENT OF VITAMIN B12 AND HOMOCYSTEINE LEVELS IN PREGNANT WOMEN ADMITTED FOR DELIVERY AND CORD BLOOD SAMPLES OF THEIR NEWBORN BABIES: A MULTICENTER STUDY
Zeynep Yildiz Yildirmak, Dildar Bahar Genç, Alev Kural, Veli Mihmanli, Suleyman Salman, Keziban Doğan, Mehmet Ali Çiftçi, Nazli Doktur Efeoğlu, ... Ebru Kale
Hematol Transfus Cell Ther. 2023;45 Supl 3:S23
Full text access
A GHOSAL HEMATODIAPHYSEAL DYSPLASIA CASE; EXCELLENT RESPONSE TO NON-STEROIDAL ANTI-INFLAMATORY DRUG TREATMENT
Hasan Fatih Cakmaklı, Hatice Mutlu, Şule Altıner, Fatma Aydın, Talia Ilerı, Elif Ince, Mehmet Ertem
Hematol Transfus Cell Ther. 2023;45 Supl 3:S23-S24
Full text access
THE SIGNIFICANCE OF NEXT-GENERATION SEQUENCING IN NON-IMMUNE HEMOLYTIC ANEMIAS AMONG NORMOCHROMIC-NORMOCYTIC ANEMIAS
Hatice Mine Cakmak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S24-S25
Full text access
A NEXT-GENERATION SEQUENCING TEST FOR CONGENITAL NEUTROPENIA IN PEDIATRIC PATIENTS
Ayça Koca Yozgat, Fatma Burçin Kurtipek, Zeliha Güzelküçük, Dilek Kaçar, Turan Bayhan, Namık Yaşar Özbek, Neşe Yaralı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S25
Full text access
BK-VIRUS INFECTIONS IN PEDIATRIC LEUKEMIA PATIENTS DURING LEUKEMIA TREATMENT
Dilek Kaçar, Zeliha Güzelküçük, Ayça Koca Yozgat, Melek Işık, Neşe Yaralı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S25
Full text access
MOLECULAR CHARACTERISTICS AND TREATMENT RESPONSE TO COG ALL PROTOCOL IN CHILDREN; A 16-YEAR SINGLE-CENTER STUDY
Cengiz Canpolat, Bengisu Güner, Mohamed Dalla, Funda Çorapcıoğlu, Meltem Kilercik
Hematol Transfus Cell Ther. 2023;45 Supl 3:S26
Full text access
INVESTIGATION OF SALİVARY MIR-9 AND SERUM CIP2A LEVELS IN FANCONI ANEMIA PATIENTS AT HIGH RISK OF DEVELOPING ORAL SQUAMOUS CELL CARCINOMA
Zişan Asal Kılıç, Çetin Timur, Tülin Tiraje Celkan, Şahin Öğreden, Nevin Yalman
Hematol Transfus Cell Ther. 2023;45 Supl 3:S26
Full text access
BUSULFAN-CYCLOPHOSPHAMIDE OR TREOSULFAN-FLUDARABINE-THIOTEPA-BASED MYELOABLATIVE CONDITIONING FOR CHILDREN WITH THALASSEMIA MAJOR, SINGLE CENTRE EXPERIENCE
Nihan Bayram, Yontem Yaman, Isik Odaman Al, Kursat Ozdilli, Murat Elli, Sema Anak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S27-S28
Full text access
EFFECT OF GRAFT VERSUS HOST DISEASE PROPHYLAXIS ON THE LEUKEMIA FREE SURVIVAL IN PEDIATRIC PATIENTS WHO HEMATOPOETIC STEM CELL TRANSPLANTED FOR LEUKEMIA
Özge Aylin Boran, İkbal Ok Bozkaya, Mehtap Olcar Kanbur, Özlem Arman Bilir, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2023;45 Supl 3:S28
Full text access
LANGERHANS CELL HISTIOCYTOSIS IN TURKISH CHILDREN; 30 YEARS OF EXPERIENCE FROM A SINGLE CENTER
Selma CAKMAKCI, Arzu YAZAL ERDEM, Derya OZYORUK, Neriman SARI, Seda SAHIN, Meriç KAYMAK CIHAN, Suna Emir, İnci ERGURHAN ILHAN
Hematol Transfus Cell Ther. 2023;45 Supl 3:S28-S29
Full text access
EVALUATION OF VIRAL RESPIRATORY TRACT INFECTIONS IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS BEFORE COVID-19 PANDEMY
Deniz Tugcu, Leyla Valıyeva, Sifa Sahın, Rumeysa Tuna, Mustafa Bılıcı, Ayşegül Unuvar, Serap Karaman, Gülşah Tanyıldız, ... Zeynep Karakas
Hematol Transfus Cell Ther. 2023;45 Supl 3:S29
Full text access
LONG-TERM EVALUATİON RESULTS OF OUR PATİENTS DİAGNOSED WİTH NASOPHARYNGEAL CARCİNOMA: A SİNGLE CENTER EXPERİENCE
Aytül Temuroglu, Candan Abakay, Betül Sevınır
Hematol Transfus Cell Ther. 2023;45 Supl 3:S30
Full text access
Poster presentations
CYTARABİNE-İNDUCED NEUROTOXİCİTY WELL-RESPONDİNG TO METHYL PREDNİSOLONE
Berrin Balik Aydin
Hematol Transfus Cell Ther. 2023;45 Supl 3:S31
Full text access
REACTIVATION OF HEPATITIS B IN A PATIENT WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Sinan Demircioğlu, Atakan Tekinalp, Ali Demir
Hematol Transfus Cell Ther. 2023;45 Supl 3:S31-S32
Full text access
ESTABLISHMENT OF EX VIVO DRUG SENSITIVITY SCREENING PLATFORM FOR LEUKAEMIA AND MULTIPLE MYELOMA USING A SOUTH AFRICAN PATIENT COHORT
Vanelle Kenmogne L, Austin Malise Thudzelani Takalani, Ekene Emmanuel Nweke, Mutsa M Takundwa, June Fabian, Heather Maher, Justin Du Toit, Vinitha Philip-Cherian, ... Deepak Balaji Thimiri Govindaraj
Hematol Transfus Cell Ther. 2023;45 Supl 3:S32-S33
Full text access
IBRUTINIB RELATED NEUROPATHY: A CASE REPORT
Zeynep Tuğba Güven, Nesibe Taşer Kanat, Neslihan Mandacı Şanlı, Ali Ünal
Hematol Transfus Cell Ther. 2023;45 Supl 3:S33
Full text access
RİCHTER SYNDROME TRANSFORMATİON UNDER VENETOCLAX TREATMENT: A CASE REPORT OF A 51-YEAR-OLD FEMALE WİTH CLL
İbrahim Halil Açar, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S33-S34
Full text access
BIOMEDICAL ANALYSIS OF RED BLOOD CELLS IN POLYCYTHEMIA VERA, APPLICATION OF RAMAN SPECTROSCOPY
Weronika Lebowa, Jakub Dybaś, Stefan Chłopicki, Tomasz Sacha
Hematol Transfus Cell Ther. 2023;45 Supl 3:S34
Full text access
DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN TUNISIAN CHRONIC MYELOID LEUKEMIA PATIENTS
Rim FRIKHA, Moez ELLOUMI, Hassen KAMOUN
Hematol Transfus Cell Ther. 2023;45 Supl 3:S34-S35
Full text access
AZERBAIJAN EXPERIENCE OF HAEMOPHILIA CARE
Gunel Alızada, Mehpara Kazımova, Elmira Gadımova, Hikmet Ibrahımlı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S35
Full text access
CHARACTERIZATION AND MANAGEMENT OF PATIENTS WITH HEREDITARY FACTOR X DEFICIENCY: A RETROSPECTIVE SINGLE CENTER EXPERIENCE
Nigar Abdullayeva, Fahri Sahin, Zuhal Demirci, Bahar Sevgili
Hematol Transfus Cell Ther. 2023;45 Supl 3:S35-S36
Full text access
REACTION OF THE CIRCULATING REGULATORY T CELLS AFTER CHEMORADIATION THERAPY OF HODGKIN LYMPHOMA
Tatiana Mushkarina, Evgenija Kuzmina, Tatiana Bogatyreva, Ludmila Grivtsova
Hematol Transfus Cell Ther. 2023;45 Supl 3:S36
Full text access
CUTANEOUS RICHTER TRANSFORMATION IN THE 16TH YEAR OF FOLLICULAR LYMPHOMA DIAGNOSIS
Ulviyya Hasanzade, Yunus Catma, Nur Seda Ibılı Cetınkaya, Beyza Oluk, Simge Erdem, Cem Hacıalıoglu, Ahmet Oguz Celık, Musa Falay, Sevgi Kalayoglu Besısık
Hematol Transfus Cell Ther. 2023;45 Supl 3:S36
Full text access
AUTOLOGOUS HEMATOPOIETC CELL TRANSPLANTATION (HCT) FOR HODGKIN LYMPHOMA, REAL WORLD EXPERIENCE OF A SINGLE CENTER EXPERIENCE
Carmino De Souza, Marcos Colella, Eliana Miranda, Lorena Bedotti, Afonso Vigorito
Hematol Transfus Cell Ther. 2023;45 Supl 3:S36-S37
Full text access
SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION AS CENTRAL NERVOUS SYSTEM LYMPHOMA RELAPSE SIGN OF NODAL DIFFUSE LARGE B-CELL LYMPHOMA
Nur Seda İbili Çetinkaya, Ulviya Hasanzade, Gülşah Alagöz, Nur Rana Karakaya, Nigar Ağzada, Mehmet Babüroğlu, Sevgi Beşışık
Hematol Transfus Cell Ther. 2023;45 Supl 3:S37
Full text access
INFECTION RATES ACROSS THE AUTOLOGOUS STEM CELL TRANSPLANTATION WITH REFLECTION OF MULTIPLE MYELOMA INDUCTION STORY IN TURKEY
Shirkhan Amikishiyev, Sevgi Kalayoglu Besisik, Ipek Yonal Hindilerden, Mustafa Nuri Yenerel, Arif Atahan Cagatay, Simge Erdem, Gulkan Ozkan, Meliha Nalcaci, Deniz Sargin
Hematol Transfus Cell Ther. 2023;45 Supl 3:S37
Full text access
DEVELOPMENT OF GIANT PLASMACYTOMA IN A PATIENT WITH BONE MARROW RESPONSE DURING TREATMENT: A CASE REPORT
Rafiye Ciftciler, Serhat Sayın, Mehmet Daglı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S38
Full text access
A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAPLACIZUMAB WITHOUT FIRST-LINE THERAPEUTIC PLASMA EXCHANGE IN ADULTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
Sriya GUNAWARDENA, Angela HU, Laurel A. MENAPACE, Hikaru OKADA, Beverly ACCOMANDO, Julie LIN
Hematol Transfus Cell Ther. 2023;45 Supl 3:S38-S39
Full text access
THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA IN PATIENTS WITH LOW-RISK OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROME: RETROSPECTIVE MULTI-CENTER REAL-LIFE STUDY
Müzeyyen Aslaner Ak, Birsen Sahip, Ayfer Geduk, Mehmet Ali Uçar, Hacer Kale, Tugba Hacibekiroglu, Merve Gokcen Polat, Yasin Kalpakcı, ... Sehmus Ertop
Hematol Transfus Cell Ther. 2023;45 Supl 3:S39
Full text access
RETROSPECTIVE EVALUATION OF BONE MARROW FINDINGS IN AUTOIMMUNE HEMOLYTIC ANEMIAS
Eren Arslan Davulcu, Tarık Onur Tiryaki, Elif Aksoy, Emine Gültürk, İpek Yönal Hindilerden, Meliha Nalçacı, Fehmi Hindilerden
Hematol Transfus Cell Ther. 2023;45 Supl 3:S39-S40
Full text access
LOCALIZED AL AMYLOIDOSIS OF THE URINARY BLADDER PRESENTING WITH PAINLESS MASSIVE HEMATURIA
Kıvanç Koruk, Murat Özbalak, Ali Altay, Gülçin Yeğen, Sevgi Beşışık Kalayoğlu
Hematol Transfus Cell Ther. 2023;45 Supl 3:S40
Full text access
A Rare Cause Of Lymphadenopathy: Kikuchi Fujimoto
Gülcan Erbaş
Hematol Transfus Cell Ther. 2023;45 Supl 3:S40
Full text access
A RARE CAUSE OF CYANOSIS: HEMOGLOBIN KANSAS
Metban Mastanzade, Alper Koç, Mustafa Hakan Demirbaş, Serkan Özen
Hematol Transfus Cell Ther. 2023;45 Supl 3:S40-S41
Full text access
CAN RADIOTHERAPY INDUCE A CLINICAL RESPONSE WITH OCCASIONAL LONG-TERM REMISSION IN RECURRENT GRANULOSA CELL TUMORS OF THE OVARY?
Ebtihaj Hassan, Suad Enaami
Hematol Transfus Cell Ther. 2023;45 Supl 3:S41
Full text access
A CASE OF DAPSONE-INDUCED HEMOLYTİC ANEMİA RELATED TO G6PD ENZYME DEFİCİENCY
Ali Dogan, Omer Ekıncı, Narin Yıldırım Dogan, Sinan Demırcıoglu, Cengiz Demır, Cihan Ural, Ramazan Esen
Hematol Transfus Cell Ther. 2023;45 Supl 3:S41-S42
Full text access
UNRAVELING BLOOD DONOR DEFERRAL TRENDS: A REAL-WORLD SINGLE-CENTER STUDY
İbrahim Halil Açar, Şule Menziletoğu Yıldız, Birol Güvenç
Hematol Transfus Cell Ther. 2023;45 Supl 3:S42
Full text access
EVALUATION OF THROMBOSIS RISK FACTORS AND PROGNOSIS IN CHILDHOOD THROMBOSIS
Mehmet Fatih Alpkiray, Aysegul Unuvar
Hematol Transfus Cell Ther. 2023;45 Supl 3:S42-S43
Full text access
SLEEP QUALITY IN PATIENTS WITH Β-THALASSAEMIA MAJOR
Ali Özdemir, Funda Erkasar, Şefika Toga
Hematol Transfus Cell Ther. 2023;45 Supl 3:S43
Full text access
IS THERE AN ASSOCIATION BETWEEN PULMONARY EMBOLISM AND THE USE OF PEG-ASPARAGINASE IN CHILDREN WITH LEUKEMIA?
Emine Yılmaz Orulluoğlu, Zühre Kaya, Merve Yazol, Büşra Topuz Turkcan, Serap Kirkiz Kayalı, Ülker Koçak
Hematol Transfus Cell Ther. 2023;45 Supl 3:S43-S44
Full text access
A PEDIATRIC CHRONIC EOSINOPHILIC LEUKEMIA CASE SUCCESFULLY TREATED WITH STEM CELL TRANSPLANTATION AFTER TRANSFORMATION TO ACUTE LYMPHOBLASTIC LEUKEMIA
Hasan Fatih Cakmaklı, Hatice Erkol Tuncer, Esra Pekpak Sahınoglu, Elif Unal Ince, Talia Ilerı, Mehmet Ertem
Hematol Transfus Cell Ther. 2023;45 Supl 3:S44
Full text access
A COMPARATIVE STUDY OF CONVENTIONAL BLOOD CULTURE METHOD VS SEPSIS QPCR MX-30 ® PANEL IN PATIENTS WITH PEDIATRIC LEUKEMIA
F.Burçin Kurtipek, Ayca Koca Yozgat, Zeliha Güzelküçük, Bedia Dinç, Dilek Gürlek Gökçebay, Namık Yaşar Özbek, Neşe Yaralı
Hematol Transfus Cell Ther. 2023;45 Supl 3:S44
Full text access
EVALUATION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN PATIENTS WITH SICKLE CELL ANEMIA
Şule Çalışkan Kamış, Defne Ay Tuncel, Begül Yağcı-Küpeli
Hematol Transfus Cell Ther. 2023;45 Supl 3:S44-S45
Full text access
VIRAL INFECTIONS IN PEDIATRIC HEAMTOPOIETIC STEM CELL TRANSPLANT PATIENTS
Irem Bozkurt, Ikbal Ok Bozkaya, Ozlem Arman Bılır, Mehtap Kanbur, Namık Yasar Ozbek
Hematol Transfus Cell Ther. 2023;45 Supl 3:S45
Full text access
EVALUATION OF MENSTRUATION RELATED QUALITY OF LIFE IN ADOLESCENTS WITH ABNORMAL UTERINE BLEEDING
Mine Dedeoğlu, Neşe Yaralı, Alkım Akman, Demet Taş
Hematol Transfus Cell Ther. 2023;45 Supl 3:S45-S46
Full text access
NEUROBLASTOMA AND ASSOCIATED DISORDERS, A SINGLE CENTER EXPERIENCE
Arzu Yazal Erdem, Selma Çakmakcı, Seda Şahin, Derya Özyörük, Neriman Sarı, Suna Emir, İnci Ergürhan İlhan
Hematol Transfus Cell Ther. 2023;45 Supl 3:S46
Full text access
TWO RARE CASES OF SUBGLOTTIC HEMANGIOMA TREATED WITH PROPRANOLOL
Melda Berber Hamamcı, Şule Yeşil, Firdevs Aydın, Gülcan Erbaş, Deniz Tuğcu, Şifa Şahin, Zuhal Bayramoğlu, Yasin Ateş, ... Zeynep Karakaş
Hematol Transfus Cell Ther. 2023;45 Supl 3:S46-S47
Full text access
A RARE INTERSECTİON: COEXİSTENCE OF BREAST CANCER AND SİCKLE CELL DİSEASE İN A 40- YEAR-OLD FEMALE - A CASE REPORT
Birol Güvenç, İdil Yürekli, Berksoy Şahin
Hematol Transfus Cell Ther. 2023;45 Supl 3:S47
Full text access
SECONDARY BRAIN TUMORS IN THE SURVIVORS OF CHILDHOOD LEUKEMIA
Nida Erbaş, Mehmet Kantar, Eda Ataseven, Serra Kamer, Cenk Eraslan, Yeşim Ertan
Hematol Transfus Cell Ther. 2023;45 Supl 3:S48
Full text access
Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.